ATOS trade ideas
ATOS making noiseThis stock has been on my radar and I passed on it when it was cheaper. I have taken a position now and it appears to have made a nice bull-flag on the daily and hourly chart. I have had some good fortune in this sector lately and would encourage others to take a look as well. A realistic S/T target is $3.70 and has the potential to move significantly higher with good news. Volume has increased 5 fold - a HUGE positive.
ATOS set to soarATOS long term graph already set to continue its rise. Additionally, today, Dr. Steven C. Quay, President and CEO, will speak at the 2021 Precision Medicine World Conference “21st Century Precision Medicine in the Age of COVID-19” about “Development of New SARS-CoV-2 Therapeutics.” Get in while you can!
PENNY STOCK: ATOSNot much into these, but we've found a floor here, lot's of upside on this company.
Atossa Therapeutics, Inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the United States. The company's lead program is the development of Endoxifen, an active metabolite of tamoxifen which is in Phase II studies to treat and prevent breast cancer. It is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and Chimeric Antigen Receptor T-cell therapies, directly to the site of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.
ATOS might found bottomATOS is currently building up volume and the long term down trend has been broken. However, 100 and 200 MA might make it retest the bottom at around .80 before heading higher.
We are still in a smaller down trend which has to be broken first. Just keep an eye on it. If you're deciding to go long, I'd recommend to have a stop loss set closely below the .80 support.